Literature DB >> 9492279

Multidrug-resistance drug-binding peptides generated by using a phage display library.

M Popkov1, I Lussier, V Medvedkine, P O Estève, V Alakhov, R Mandeville.   

Abstract

A phage display library of random decapeptides was used to generate peptide ligands that can bind multidrug-resistance (MDR) drugs mimicking, in this respect, the drug-binding activity of P-glycoprotein. Seven peptide sequences were identified that specifically bound doxorubicin. Five of these sequences expressed the core consensus motif WXXW. The displacement assay showed that the phages expressing these peptides bound MDR type drugs (vinblastine, doxorubicin, verapamil, and genistein) with the same selectivity as P-glycoprotein and did not interact with non-MDR type drugs, such as arabinosylcytosine (Ara-C) and melphalan. One of the selected peptides that showed a highest capacity for the binding (VCDWWGWGIC) was synthesized and displayed competition with the phage for doxorubicin binding. The structure modeling suggested that all the selected sequences contained a hydrophobic envelope in which MDR drugs could be docked with substantial energy minimization. Western blot analysis showed that monospecific antibody obtained against the phage expressing VCDWWGWGIC peptide could specifically recognize P-glycoprotein in the membrane fraction of MDR phenotype MCF-7ADR cells. The MDR drug-binding sequences generated during this work could provide an important tool for design and screening of new chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9492279     DOI: 10.1046/j.1432-1327.1998.2510155.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Acquired resistance of leukemic cells to AraC is associated with the upregulation of aldehyde dehydrogenase 1 family member A2.

Authors:  Misaki Kawasoe; Yasuko Yamamoto; Katsuya Okawa; Tadao Funato; Mayu Takeda; Takeshi Hara; Hisashi Tsurumi; Hisataka Moriwaki; Yuko Arioka; Masao Takemura; Hidetoshi Matsunami; Sanford P Markey; Kuniaki Saito
Journal:  Exp Hematol       Date:  2013-03-15       Impact factor: 3.084

2.  Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers.

Authors:  Jihua Hao; Adrian W R Serohijos; Gail Newton; Gina Tassone; Zuncai Wang; Dennis C Sgroi; Nikolay V Dokholyan; James P Basilion
Journal:  PLoS Comput Biol       Date:  2008-08-01       Impact factor: 4.475

3.  Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein.

Authors:  G L Scheffer; A W Reurs; B Jutten; S H W Beiboer; R van Amerongen; M Schoester; E A C Wiemer; H R Hoogenboom; R J Scheper
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.